{
  "meta": {
    "title": "104_Covid_19_-_Prophylaxis_And_Complications",
    "url": "https://brainandscalpel.vercel.app/104-covid-19-prophylaxis-and-complications-aa8a7439.html",
    "scrapedAt": "2025-11-30T12:28:23.596Z"
  },
  "questions": [
    {
      "text": "Your worried friend calls you for advice after attending a family function. He informs you that his aunt, who also travelled to the function in the same car, tested positive for COVID-19. What is your advice for your friend?",
      "choices": [
        {
          "id": 1,
          "text": "Home isolation for 14 days"
        },
        {
          "id": 2,
          "text": "Home quarantine for 14 days"
        },
        {
          "id": 3,
          "text": "Home quarantine for 10 days"
        },
        {
          "id": 4,
          "text": "Home isolation for 10 days"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Home quarantine for 14 days</strong> is advised when a person comes in contact with a COVID-19 positive patient.</p>\n<p>The home quarantined person:</p>\n<ul>\n<li>Should stay in a well ventilated single room and&nbsp;stay away from high-risk individuals</li>\n<li>Should not attend any religious or social gatherings</li>\n<li>Must wash hands often</li>\n<li>Must change mask every 6-8 hrs</li>\n<li>Their surroundings must be disinfected with 1% sodium hypochlorite solution</li>\n</ul>\n<p>In case the person being quarantined becomes symptomatic, all his contacts should be home quarantined for 14 days and followed up for another 14 days or till the report turns out negative on lab testing.</p>\n<p><strong>Isolation</strong> is the separation and restriction of movements or activities of persons who are <strong>sick</strong>, to prevent the transmission of disease.&nbsp;<strong>Quarantine</strong> is the separation and restriction of movements or activities of persons who are <strong>not ill</strong> but are believed to have been<strong> exposed</strong> to infection, for the purpose of preventing transmission of diseases.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3922",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man recovering from COVID-19 presents as follows. His medical and personal histories are insignificant with no exposure to cold. What would you suspect?",
      "choices": [
        {
          "id": 1,
          "text": "Chilblains"
        },
        {
          "id": 2,
          "text": "COVID toes"
        },
        {
          "id": 3,
          "text": "Varicella"
        },
        {
          "id": 4,
          "text": "Eczema"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>COVID toes</strong>. The image shows pernio-like lesions caused due to COVID-19.</p>\n<p><strong>Pernio / chilblains</strong> are skin lesions on the acral surfaces of the body characterised by the development of erythematous-violaceous or <strong>purpuric macules</strong>. They may be accompanied by edema and pruritus.&nbsp;</p>\n<p>It is usually due to cold exposure or underlying hematological disorders but has also been reported in patients with COVID-19 disease. The underlying mechanism is thought to be an inflammatory process. The lesions appear late (<strong>postviral phase</strong>) with the patients exhibiting <strong>positive&nbsp; IgM/ IgG </strong>antibodies for SARS-CoV-2 and <strong>negative RT-PCR</strong>. However, pernio like lesions can also be seen in early stages of the disease when the patients are still infective.&nbsp;</p>\n<p>There are no treatment guidelines but <strong>high-potency topical corticosteroids</strong> may be helpful if the lesions are causing discomfort. Other cutaneous manifestations include&nbsp;exanthematous rash, livedo reticularis, urticaria, MIS-C etc.&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/659da52e46934adbb21f851fade520a5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3918",
      "difficulty": "easy"
    },
    {
      "text": "While donning a set of PPE, what is the order that you will follow?<div class='question-desc-html'><ol>\n<li>Coverall</li>\n<li>First pair of gloves</li>\n<li>Shoe cover</li>\n<li>N-95 mask</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2→1→3→4"
        },
        {
          "id": 2,
          "text": "1→2→3→4"
        },
        {
          "id": 3,
          "text": "1→2→4→3"
        },
        {
          "id": 4,
          "text": "2→1→4→3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct sequence of donning a PPE is<strong>&nbsp;first pair of gloves&nbsp;&rarr; coverall&nbsp;&rarr; Shoe cover&nbsp;&rarr; N-95 mask.</strong></p>\n<p><strong>Preparation for donning the PPE:</strong></p>\n<ul>\n<li>To be performed only in the designated area</li>\n<li>The health care worker must be prepared for the shift duty by\n<ul>\n<li>Taking a meal</li>\n<li>Using the washroom</li>\n<li>Drinking water prior to entering the donning area</li>\n</ul>\n</li>\n<li>Remove all accessories, jewelry</li>\n<li>Change into clean hospital scrubs and closed washable footwear</li>\n<li>Perform hand hygiene with soap and water</li>\n</ul>\n<p><strong>Steps of donning/putting on the PPE:&nbsp;</strong></p>\n<ul>\n<li>Hand hygiene&nbsp;</li>\n<li>Wear the first pair of gloves\n<ul>\n<li>Sterile or unsterile</li>\n<li>Make sure the cuff of the gloves goes as far as possible</li>\n</ul>\n</li>\n<li>Examine and wear coverall\n<ul>\n<li>Examine the coverall for any damage</li>\n<li>Start by wearing the leg sleeves and then the arm sleeves</li>\n<li>Zip up and cover the zip with the flap attached</li>\n</ul>\n</li>\n<li>Wear shoe cover\n<ul>\n<li>Sit on the clean chair and wear shoe cover</li>\n<li>Pull them up till your calves</li>\n</ul>\n</li>\n<li>Wear N-95 mask and wear hood\n<ul>\n<li>Hold the mask like a cup in the hand with both the straps hanging out in the front</li>\n<li>Place the mask on the face, pull and wear the lower strap first placing it below the ears</li>\n<li>Then pull and wear the upper strap placing above the ears</li>\n<li>The air leakage should be minimum around the mask when forcibly exhaling</li>\n<li>Wear the hood covering the forehead and the cheeks</li>\n</ul>\n</li>\n<li>Wear face shield/eye goggles&nbsp;over the hood and ensure the fit</li>\n<li>Wear the second pair of gloves - pull the gloves to cover the sleeve cuff and forearm as much as possible</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6852",
      "difficulty": "medium"
    },
    {
      "text": "While doffing, what is the first component of the PPE that you would remove?",
      "choices": [
        {
          "id": 1,
          "text": "Coverall"
        },
        {
          "id": 2,
          "text": "Shoe covers"
        },
        {
          "id": 3,
          "text": "Face shield"
        },
        {
          "id": 4,
          "text": "Gloves"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The component of the PPE kit to be removed first is the <strong>shoe covers.</strong></p>\n<p><strong>Preparation for doffing the PPE:</strong></p>\n<ul>\n<li>To be performed only in the designated area</li>\n<li>Check for any leak or soiling</li>\n<li>Doffing room should have two chairs, dirty and clean</li>\n<li>All the PPE must be discarded in the red bin</li>\n<li>Hand hygiene must be performed after every step</li>\n</ul>\n<p><strong>Steps of doffing the PPE:</strong></p>\n<ul>\n<li>Engage the observer and ask him to check the PPE - observer should check for any leak, tear, or contamination of PPE. If contaminated, then it should be disinfected with alcohol-based wipes.</li>\n<li>Disinfect the gloves</li>\n<li>Remove and discard shoe covers\n<ul>\n<li>Sit on the dirty chair with legs apart</li>\n<li>Remove the shoe covers by slowly pulling the outer surface starting from the top and then pull from the toes end. Discard them</li>\n</ul>\n</li>\n<li>Disinfect and remove outer pair of gloves\n<ul>\n<li>While removing the outer gloves, inner gloves should not be torn or contaminated</li>\n<li>Pinch the first glove on the outer surface at the wrist and pull it inside out</li>\n<li>Hold this glove in the other hand like a ball</li>\n<li>Slide the thumb inside the other glove and remove inside out balling around the previous glove, making it into a single bag. Then discard it.</li>\n</ul>\n</li>\n<li>Disinfect inner gloves</li>\n<li>Remove face shield/eye goggle - loosen the screw and remove the face shield by holding it from the back handle. Discard it.</li>\n<li>Disinfect inner gloves again</li>\n<li>Remove hood and coverall\n<ul>\n<li>Slide back the hood by holding it from the top</li>\n<li>Separate the zip flap and unzip the coverall suit</li>\n<li>Holding the suit at the arms, slide it off the shoulder slightly, then pull the suit from the side of the waist</li>\n<li>Roll the arms out one by one</li>\n<li>By touching the inner surface of the suit carefully roll out each leg. Discard it</li>\n</ul>\n</li>\n<li>Disinfect and remove inner gloves as previously described</li>\n<li>Perform hand hygiene and wear a new pair of gloves</li>\n<li>Remove and discard N-95 mask\n<ul>\n<li>Do not touch the exposed surface of the mask</li>\n<li>Stoop forward and first remove the lower strap</li>\n<li>Then pull out the upper strap and remove the mask</li>\n</ul>\n</li>\n<li>Disinfect gloves</li>\n<li>Sit on the clean chair and disinfect shoes using alcohol wipes</li>\n<li>Disinfect and remove gloves</li>\n<li>Perform hand hygiene</li>\n<li>Wipe the shoes on sodium hypochlorite soaked doormat at exit</li>\n<li>Exit the doffing area and take a shower</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6854",
      "difficulty": "hard"
    },
    {
      "text": "You are a medical officer at the designated COVID hospital in your city and are required to don PPE every day at work. Which area of the PPE should you not touch while doffing?",
      "choices": [
        {
          "id": 1,
          "text": "Earpiece / ties of the mask"
        },
        {
          "id": 2,
          "text": "Inside the mask"
        },
        {
          "id": 3,
          "text": "Front of face shield"
        },
        {
          "id": 4,
          "text": "Back of isolation gown"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The<strong> front </strong>of the <strong>face shield</strong> is considered to be a <strong>contaminated </strong>area of the&nbsp;<strong>personal protective equipment </strong>(PPE). Hence, it should not be touched while doffing.</p>\n<p>The areas that are considered <strong>clean</strong> are the parts that will be touched while removing a PPE:</p>\n<ul>\n<li>Inside the gloves&nbsp;</li>\n<li>Inside and back of the gown including the ties</li>\n<li>Ties or earpieces of the mask, goggles, and face shields</li>\n</ul>\n<p>The areas that are considered <strong>contaminated</strong> are:</p>\n<ul>\n<li>Outside front and sleeves of the isolation gown&nbsp;</li>\n<li>Front of goggles, mask, respirator, and face shield</li>\n<li>Outside of the gloves</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6825",
      "difficulty": "medium"
    },
    {
      "text": "After your COVID ICU shift, where would you dispose your face shield?",
      "choices": [
        {
          "id": 1,
          "text": "Red bin"
        },
        {
          "id": 2,
          "text": "Black bag"
        },
        {
          "id": 3,
          "text": "Yellow bin"
        },
        {
          "id": 4,
          "text": "White bag"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>face shield</strong> used by a <strong>healthcare worker</strong> during COVID-19 pandemic is disposed in the <strong>red bin</strong>.</p><hr><h3>Related Pearl: Biomedical Waste (BMW) Management -COVID 19</h3><p>In addition to the current BMW Management rules, the following measures are proposed</p>\n<ul>\n<li>To report opening/operation of COVID 19 Ward/ICU/Lab/Collection Centre to <strong>SPCB</strong> (State Pollution Control Board) and <strong>CBWTF</strong> (Common Biomedical Waste Treatment Facility) in that area</li>\n<li>Dedicated sanitation workers deputed only to collect COVID 19 BMW</li>\n<li>It is mandatory for all BMW bags and containers from COVID 19 areas to carry <strong>\"COVID 19 WASTE\"</strong> label</li>\n<li>Keep separate colour coded bins with <strong>foot operated lids</strong></li>\n<li>The inner and outer surfaces of these containers must be disinfected daily with <strong>1% sodium hypochlorite</strong> solution</li>\n<li>To ensure no leaks, <strong>double layers&nbsp;</strong>(2 bags) are used</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>COLOUR OF THE BIN</strong></td>\n<td><strong>PERSONAL PROTECTIVE EQUIPMENT(PPE)</strong></td>\n<td><strong>OTHER WASTE</strong></td>\n</tr>\n<tr>\n<td><strong>Red Bin</strong></td>\n<td>\n<ul>\n<li>Goggles</li>\n<li>Face shield&nbsp;</li>\n<li>Splash-proof apron</li>\n<li>Plastic coverall</li>\n<li>Hazmat suit</li>\n<li>Nitrile gloves</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Used gloves</li>\n</ul>\n<p><strong>Laboratory waste</strong></p>\n<ul>\n<li>Pre-treated viral transport media</li>\n<li>Plastic vials and cryovials</li>\n<li>Vacutainers</li>\n<li>Eppendorf tubes</li>\n<li>Pipette tips</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Yellow Bin</strong></td>\n<td>\n<ul>\n<li>Used mask(triple layer mask, N95 mask)</li>\n<li>Head cover/Cap, Shoe cover</li>\n<li>Disposable linen gown&nbsp;</li>\n<li>Non-plastic/Semi-plastic coverall</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Diapers with feces of immobile COVID 19 patients&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3926",
      "difficulty": "medium"
    },
    {
      "text": "What is recommended for cleaning and disinfecting a healthcare facility against COVID-19?",
      "choices": [
        {
          "id": 1,
          "text": "1% formaldehyde"
        },
        {
          "id": 2,
          "text": "1% glutaraldehyde"
        },
        {
          "id": 3,
          "text": "35%  isopropyl alcohol"
        },
        {
          "id": 4,
          "text": "1% sodium hypochlorite"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>1% sodium hypochlorite</strong> is recommended for cleaning and disinfection against COVID-19.</p>\n<p>The sodium hypochlorite solution should be prepared fresh. Leaving the solution for a contact time of at least <strong>10 minutes</strong> is recommended.</p>\n<p>Note: <strong>Alcohol</strong> (e.g. isopropyl 70% or ethyl alcohol 70%) can be used to wipe down surfaces where the use of bleach is not suitable, e.g. <strong>metals.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3920",
      "difficulty": "medium"
    },
    {
      "text": "Identify the wrong match regarding COVID-19 vaccines:",
      "choices": [
        {
          "id": 1,
          "text": "Pfizer - mRNA based vaccine"
        },
        {
          "id": 2,
          "text": "Covaxin - Inactivated vaccine"
        },
        {
          "id": 3,
          "text": "Moderna - Recombinant DNA vaccine"
        },
        {
          "id": 4,
          "text": "AstraZeneca - Non-replicating viral vector vaccine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>Moderna COVID-19 vaccine</strong> is also an <strong>mRNA-based</strong> vaccine.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Vaccines</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>Pfizer/BioNtech (Comirnaty)</td>\n<td>mRNA based vaccine&nbsp;</td>\n</tr>\n<tr>\n<td>Moderna</td>\n<td>mRNA based vaccine&nbsp;</td>\n</tr>\n<tr>\n<td>Oxford University/ Astra Zeneca/ Serum Institute of India (Covishield)</td>\n<td>Non-replicating viral vector</td>\n</tr>\n<tr>\n<td>Gamaleya (Sputnik V)/ Dr.Reddys</td>\n<td>Non-replicating viral vector</td>\n</tr>\n<tr>\n<td>Johnson and Johnson&nbsp;(Janssen&nbsp;Ad26.CoV2.S)</td>\n<td>Non-replicating viral vector</td>\n</tr>\n<tr>\n<td>Bharat biotech/NIV (Covaxin)</td>\n<td>Inactivated vaccine</td>\n</tr>\n<tr>\n<td>Zydus Cadila (ZyCoV-D)</td>\n<td>Plasmid DNA vaccine</td>\n</tr>\n<tr>\n<td>Novavax&nbsp;</td>\n<td>Protein subunit</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><p>The Drugs Controller General of India (DCGI) has granted permission for <strong>restricted emergency use</strong> of the following vaccines against COVID-19:</p>\n<ul>\n<li><strong>Covaxin</strong> (Bharat biotech/NIV)</li>\n<li><strong>Covishield</strong> (Oxford University/ AstraZeneca/ Serum Institute of India)</li>\n<li><strong>Sputnik V&nbsp;</strong>(Gamaleya Research Institute/ Dr. Reddy's Laboratories)</li>\n<li><strong>ZyCoV-D</strong> (Zydus Cadila)</li>\n</ul>\n<p>The FDA has issued an emergency use authorization for the following vaccines against COVID-19:&nbsp;</p>\n<ul>\n<li><strong>Pfizer/BioNtech</strong></li>\n<li><strong>Moderna</strong></li>\n<li><strong>Johnson and Johnson</strong></li>\n</ul>\n<p>According to the new vaccine guidelines by<strong> NEGVAC</strong> (National Expert Group on Vaccine Administration for COVID-19):</p>\n<ol>\n<li>Vaccination is to be deferred by <strong>3 months</strong> in the following persons:&nbsp;\n<ul>\n<li>Individuals (proven positive) recovered from the disease.</li>\n<li>Recipients of monoclonal antibodies or convalescent plasma.</li>\n<li>2<sup>nd</sup> dose is to be deferred by 3 months if infected with COVID after 1<sup>st</sup> dose.&nbsp;</li>\n</ul>\n</li>\n</ol>\n<ol>\n<li><strong>4-8 weeks</strong> gap, after recovery of patients with other serious illnesses requiring hospitalization/ICU care.</li>\n<li>Blood donation: Wait for <strong>14 days</strong> after receiving the vaccine/testing RT-PCR negative.</li>\n<li><strong>No screening</strong>&nbsp;is required by rapid antigen test (RAT) prior to vaccination.</li>\n<li>Recommended for all lactating women.</li>\n</ol>\n<p><strong>COVID-19 vaccination during pregnancy:</strong></p>\n<ul>\n<li aria-level=\"1\">MoHFW has recently approved the vaccination of pregnant women against COVID-19.</li>\n<li aria-level=\"1\">COVID-19 vaccine can be taken anytime during pregnancy and <strong>should be taken at the earliest</strong>.</li>\n<li aria-level=\"1\">If any woman has been infected with COVID-19 during pregnancy, she should be vaccinated <strong>soon after delivery</strong>.</li>\n<li aria-level=\"1\">COVID-19 vaccine is safe in pregnancy.</li>\n</ul><p>FDA approved the <strong>first COVID-19 vaccine</strong> on August 23, 2021. The vaccine, earlier known as <strong>Pfizer-BioNTech</strong> COVID-19 vaccine, will now be marketed as <strong>Comirnaty</strong> for individuals&nbsp;<strong>&ge;</strong><strong>16 years </strong>of age. The vaccine also continues to be available under emergency use authorization (<strong>EUA</strong>) for <strong>12-15 years</strong> of age.&nbsp;</p>\n<p><strong>Note:</strong> India launched <strong>BBV154 (iNCOVACC)</strong>, an <strong>intranasal</strong> vaccine to provide<strong> active immunity</strong> against <strong>SARS-CoV-2</strong>&nbsp;infection.&nbsp;It can be administered in individuals&nbsp;<strong>&ge;18 years</strong> as a <strong>primary vaccine </strong>(2 doses of 0.5 ml each given 4 weeks apart) or as a <strong>heterologous booster dose </strong>(1 dose of 0.5 ml given &ge; 6 months of completing any primary schedule).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6851",
      "difficulty": "medium"
    },
    {
      "text": "Four days after being extubated, an elderly diabetic man with COVID-19 developed rhinosinusitis. The tissue obtained from the sinuses showed the following. The physician wanted to start the patient on amphotericin B. However, it was not available. Which other drug can be given to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Voriconazole"
        },
        {
          "id": 2,
          "text": "Isavuconazole"
        },
        {
          "id": 3,
          "text": "Itraconazole"
        },
        {
          "id": 4,
          "text": "Flucytosine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The&nbsp;given clinical scenario is suggestive of&nbsp;<strong>mucormycosis</strong><strong>. </strong>Intravenous administration of<strong> amphotericin B </strong>is the first line treatment. Other drugs which are approved for its management include&nbsp;<strong>isavuconazole </strong>and <strong>posaconazole.</strong>&nbsp;Surgical debridement is the last line management.</p>\n<p class=\"p1\">Immunocompromised states are important risk factors including&nbsp;<strong>diabetes mellitus </strong>and&nbsp;<strong>glucocorticoid treatment </strong>as well as patients on<strong> ventilation.&nbsp;</strong></p>\n<p class=\"p1\">Diagnosis can be made by&nbsp;culturing&nbsp;the organisms from sterile sites like needle aspirate, pleural fluid, or a tissue biopsy specimen. The&nbsp;biopsy&nbsp;is most sensitive. It reveals characteristic&nbsp;<strong>wide, thick-walled, ribbon-like, aseptate hyphal</strong>&nbsp;elements that branch at <strong>right angles</strong>.</p>\n<p class=\"p1\">It can present as:</p>\n<ul>\n<li class=\"p1\"><strong>Rhino-orbital-cerebral mucormycosis&nbsp;</strong>- (most common) the initial symptoms are nonspecific and include eye or facial pain and facial numbness followed by the onset of conjunctival suffusion and blurry vision. If untreated it can spread from the sinuses to the orbit, and then to the frontal lobe.</li>\n<li class=\"p1\"><strong>Pulmonary mucormycosis&nbsp;</strong>- (second most common)</li>\n<li class=\"p1\">Cutaneous mucormycosis&nbsp;- usually results after trauma</li>\n<li class=\"p1\">Gastrointestinal mucormycosis - primarily occurs in premature neonates who have disseminated disease or necrotizing enterocolitis</li>\n<li class=\"p1\">Disseminated mucormycosis</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4bab9392379c46eb85f2565ca6255c5c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9999",
      "difficulty": "medium"
    },
    {
      "text": "A young girl, who recently recovered from COVID-19, presents with fever, abdominal pain and rashes for 4 days. On examination, strawberry tongue is observed and cervical nodes are found to be enlarged bilaterally. What is the likely diagnosis?<div class='question-desc-html'><p>HR: 110/min</p>\n<p>BP: 80/60 mm Hg</p>\n<p>RR: 20/min</p>\n<p>CRP: 10 mg/L</p>\n<p>ESR: 76mm/hr.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Kawasaki disease"
        },
        {
          "id": 2,
          "text": "Multisystem inflammatory syndrome in children"
        },
        {
          "id": 3,
          "text": "Bacterial sepsis"
        },
        {
          "id": 4,
          "text": "Toxic shock syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This is a case of <strong>m</strong><strong>ultisystem inflammatory syndrome in children (MIS-C)</strong>, associated with<strong> COVID-19</strong> infection.</p>\n<p><strong>Diagnostic criteria for MIS-C:</strong></p>\n<p>Children and adolescents 0&ndash;18 years of age with fever &ge;3 days</p>\n<p>AND two of these:</p>\n<ul>\n<li aria-level=\"1\">Rash or bilateral non-purulent conjunctivitis or mucocutaneous inflammation signs (palmoplantar erythema,&nbsp;lip hyperemia, periorbital erythema and edema, strawberry tongue, and malar erythema)</li>\n<li aria-level=\"1\">Hypotension or shock.</li>\n<li aria-level=\"1\">Features of myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities&nbsp;(including ECHO findings or elevated Troponin/NT-proBNP)</li>\n<li aria-level=\"1\">Evidence of coagulopathy&nbsp;(PT, PTT, elevated D-Dimers)</li>\n<li aria-level=\"1\">Acute gastrointestinal problems (diarrhoea, vomiting, or abdominal pain)</li>\n</ul>\n<p>AND</p>\n<p>Elevated ESR(&gt;40 mm), C-reactive protein (&gt;5 mg/L), or procalcitonin.</p>\n<p>AND</p>\n<p>No other obvious microbial cause of inflammation including bacterial sepsis, staphylococcal or streptococcal shock syndromes.</p>\n<p>AND</p>\n<p>Evidence of COVID-19 (RT-PCR, antigen test,&nbsp;or serology positive), or likely contact with patients with COVID-19.</p>\n<p><strong>Types of MIS-C</strong>:</p>\n<ul>\n<li>MIS-C with shock/multi-organ dysfunction</li>\n<li>Kawasaki phenotype</li>\n<li>MIS-C without shock</li>\n</ul>\n<p>MIS-C is treated with <strong>IV methylprednisolone</strong>. The dose can be increased in patients with shock. If the condition does not improve for 48-72 hours, specialists can be consulted for the addition of biologicals to the treatment regimen.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7149",
      "difficulty": "easy"
    },
    {
      "text": "Which gene increases the risk of collapsing glomerulopathy in COVID-19 patients?",
      "choices": [
        {
          "id": 1,
          "text": "NPHS1"
        },
        {
          "id": 2,
          "text": "ACTN4"
        },
        {
          "id": 3,
          "text": "APOL1"
        },
        {
          "id": 4,
          "text": "TRPC6"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>APOL1 gene</strong> increases the risk of <strong>collapsing nephropathy</strong> in patients infected with COVID-19. </p>\n<p>Glomerular lesions are reported in a minority of COVID-19 patients. They are associated with collapsing focal segmental glomerulosclerosis (<strong>FSGS</strong>) and are called <strong>COVID-associated nephropathy (COVAN)</strong>. Such patients present with nephrotic-range proteinuria and acute kidney injury (<strong>AKI</strong>). It specifically affects individuals of <strong>African </strong>ancestry who are carriers of this gene variant.</p>\n<p>Thrombotic microangiopathy is another uncommon finding among these patients. Histopathology is similar to those seen in other forms of collapsing glomerulopathy. But, <strong>tubulointerstitial lesions</strong> including microcystic tubular dilatation and tubular injury are typically associated with APOL1- related disease. </p>\n<div class=\"page\" title=\"Page 9\"> </div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7307",
      "difficulty": "hard"
    },
    {
      "text": "As a healthcare worker working in a COVID hospital, you receive the following vaccine. Which of the following is not an adverse event related to this vaccine?",
      "choices": [
        {
          "id": 1,
          "text": "Cough"
        },
        {
          "id": 2,
          "text": "Tremors"
        },
        {
          "id": 3,
          "text": "Demyelinating disorder"
        },
        {
          "id": 4,
          "text": "Dizziness-giddiness"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p dir=\"ltr\"><strong>Demyelinating disorders</strong> are rare adverse events following <strong>Covishield</strong>, not Covaxin.</p>\n<p dir=\"ltr\"><strong>Composition</strong> of Covaxin:</p>\n<ul>\n<li dir=\"ltr\">Inactivated coronavirus</li>\n<li dir=\"ltr\">Aluminum hydroxide gel</li>\n<li dir=\"ltr\">TLR 7/8 agonist</li>\n<li dir=\"ltr\">2-Phenoxyethanol and</li>\n<li dir=\"ltr\">Phosphate Buffered Saline/ NKA1</li>\n</ul>\n<p>&nbsp;<strong>Adverse effects:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Covaxin</strong></td>\n<td><strong>Covishield</strong></td>\n</tr>\n<tr>\n<td>\n<p>Fever, cough, sweating</p>\n</td>\n<td>Fever and chills</td>\n</tr>\n<tr>\n<td>\n<p>Injection site pain and swelling</p>\n</td>\n<td>Injection site pain and swelling</td>\n</tr>\n<tr>\n<td>\n<p>Headache, bodyache, fatigue</p>\n</td>\n<td>Headache, malaise, fatigue</td>\n</tr>\n<tr>\n<td>\n<p>Abdominal pain, nausea, vomiting</p>\n</td>\n<td>Nausea</td>\n</tr>\n<tr>\n<td>\n<p>Dizziness, giddiness, tremor</p>\n</td>\n<td>\n<p>Myalgia, arthralgia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p dir=\"ltr\">Rarely, complications like <strong>demyelinating</strong> disorders,&nbsp;<strong>Guillain-Barre syndrome,</strong> and vaccine-induced immune thrombotic thrombocytopenia (<strong>VITT</strong>) are also seen following&nbsp;<strong>Covishield </strong>vaccine.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/70fd540698f24905a3154dcbc7c9fed0.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0490",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following patients, would you administer Covidshield vaccination?<div class='question-desc-html'><ol>\n<li><span data-preserver-spaces=\"true\">A 51-year-old man who underwent hematopoietic stem cell transplantation 5 weeks ago for aplastic anemia.&nbsp;</span></li>\n<li><span data-preserver-spaces=\"true\">A 60-year-old man with a history of type-2 diabetes mellitus.&nbsp;</span></li>\n<li><span data-preserver-spaces=\"true\">A 32-year-old woman who received TT immunization 20 days back following a trivial fall from a bike.</span></li>\n<li><span data-preserver-spaces=\"true\">A 45-year-old man on dialysis three times a week for chronic kidney disease.</span></li>\n<li><span data-preserver-spaces=\"true\">A 40-year-old woman on insulin therapy for type-1 diabetes mellitus.&nbsp;</span></li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3"
        },
        {
          "id": 2,
          "text": "1, 2, 4, 5"
        },
        {
          "id": 3,
          "text": "2, 3, 4, 5"
        },
        {
          "id": 4,
          "text": "3, 4, 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The&nbsp;<span data-preserver-spaces=\"true\">51-year-old man</span> should receive&nbsp;COVID-19 vaccination<strong>&nbsp;</strong>at least<strong> 3 months after hematopoietic cell transplantation</strong> (and not 5 weeks)&nbsp;to&nbsp;maximize vaccine efficacy.&nbsp;</p>\n<p><strong>Graft-versus-host disease</strong> and immunosuppressive regimens like systemic corticosteroids can blunt the immune responses to vaccination. Delay of vaccination until<strong> immunosuppressive therapy</strong> is reduced can be considered.&nbsp;</p>\n<p>Consider additional risk factors linked to <strong>adverse COVID-19 complications</strong> including, but not limited to:&nbsp;</p>\n<ul>\n<li>Patients with advanced age (eg, &ge;65 years of age)&nbsp;</li>\n<li>Patients with comorbidities (eg, chronic pulmonary, cardiovascular, or renal disease)&nbsp;</li>\n<li>Social and demographic factors</li>\n</ul>\n<p>COVID-19 vaccines should be prioritized over other vaccines. A gap of&nbsp;<strong>14 days</strong>&nbsp;is recommended between COVID-19 vaccines and any other vaccine.&nbsp;</p>\n<p>If COVID vaccine has been given first, then TT vaccine can be given on the same day. If TT vaccine have been given first, then wait for 14 days to give COVID vaccine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD8475",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old boy who had SARS CoV-2 infection 3 months back came with complaints of fatigue and shortness of breath for 3 days. The minimum duration of these symptoms to define it as post-Covid-19 condition according to WHO is ____",
      "choices": [
        {
          "id": 1,
          "text": "2 months"
        },
        {
          "id": 2,
          "text": "2 weeks"
        },
        {
          "id": 3,
          "text": "4 months"
        },
        {
          "id": 4,
          "text": "4 weeks"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The minimum duration of symptoms such as fatigue, shortness of breath to define it as <strong>post Covid-19</strong> condition according to WHO is <strong>2 months.</strong></p>\n<p>WHO clinical case definition of post Covid-19 - Post Covid-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually <strong>3 months from the onset</strong> of Covid-19, with symptoms that <strong>last for at least 2 months</strong> and cannot be explained by an alternative diagnosis.</p>\n<p>Common symptoms include&nbsp;</p>\n<ul>\n<li aria-level=\"1\">Fatigue</li>\n<li aria-level=\"1\">Shortness of breath</li>\n<li aria-level=\"1\">Cognitive dysfunction.</li>\n</ul>\n<p>&nbsp;</p><p>These symptoms may be new-onset <strong>following initial recovery</strong> from an acute Covid-19 episode or <strong>persist</strong> from the initial episode. They may fluctuate or relapse over time.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1980",
      "difficulty": "hard"
    }
  ]
}